The work of OMRF’s scientists has yielded more than 700 domestic and international patents. These patents speed the movement of discoveries from the bench to bedside, and each one also represents a potential new business venture. Currently, OMRF has 27 active licenses of these patents to biotechnology and pharmaceutical companies. OMRF’s patents have also formed the basis for 14 different spin-off biotechnology companies, which, in turn, fuel widespread private-sector growth.
